A Double-Blind Randomized Clinical Trial Comparing the Effect of Neostigmine and Metoclopramide on Gastric Residual Volume of Mechanically Ventilated ICU Patients

Afshin Gholipour Baradari, Abbas Alipour, Abolfazl Firouzian, Laleh Moarab, Amir Emami Zeydi, Afshin Gholipour Baradari, Abbas Alipour, Abolfazl Firouzian, Laleh Moarab, Amir Emami Zeydi

Abstract

Background: In critically ill patients, enteral feeding through the nasogastric tube is the method of choice for nutritional support. Gastrointestinal feeding intolerance and disturbed gastric emptying are common challenges in these patients. The aim of this study was to compare the effect of Neostigmine and Metoclopramide on gastric residual volume (GRV) in mechanically ventilated ICU patients.

Methods: In a double blind, randomized clinical trial, a total of 60 mechanically ventilated ICU patients with GRV >120 mL (3 hours after the last gavage), were randomly assigned into two groups A and B. At baseline and 6 hours later, patients in group A and B received intravenous infusion of neostigmine in a dose of 2.5 mg and metoclopramide in a dose of 10 mg in 100 ml of normal saline, within 30 minutes. Patients' gastric residual volumes were evaluated before the beginning of the intervention, and 3, 6, 9 and 12 hours after the intervention.

Results: After adjusting of other variables (Sex, BMI and ICU stay period) generalized estimating equation (GEE) model revealed that neostigmine treatment increased odds of GRV improvement compare to metoclopramide group (Estimate 1.291, OR= 0.3.64, 95% CI 1.07-12.34). However there is a statistically significant time trend (within-subject differences or time effect) regardless of treatment groups (P<0.001). The median time from intervention to GRV improvement was 6 hours (95% CI 3.75-8.25) and 9 hours (95% CI 7.38-10.17) in neostigmine and metoclopramide groups, respectively. This difference was statistically significant (P<0.05).

Conclusion: It seems that neostigmine is more effective than metoclopramide in reducing GRV and improving gastric emptying in mechanically ventilated ICU patients without significant complication and this protocol may be effective on the tolerance of enteral feeding in ICU patients. Further well-designed randomized clinical trials are needed.

Keywords: Gastric Residual Volume; ICU; Metoclopramide; Neostigmine.

Conflict of interest statement

• Conflict of interest: none declared

Figures

Figure 1
Figure 1
Flow chart of study population selection
Figure 2
Figure 2
Cumulative gastric residual volume improvement survival curves of 57 patients in neostigmine and metoclopramide groups

References

    1. Heyland DK, Schroter-Noppe D, Drover JW, Jain M, Keefe L, Dhaliwal R, et al. Nutrition support in the critical care setting: current practice in canadian ICUs - opportunities for improvement? JPEN J Parenter Enteral Nutr. 2003;27(1):74–83.
    1. Heydari A, Emami Zeydi A. Is gastric residual volume monitoring in critically ill patients receiving mechanical ventilation an evidence-based practice? Indian J Crit Care Med. 2014;18(4):259–60.
    1. Emami Zeydi A, Sharafkhani M, Armat MR. Gastric Residual Volume: Rethinking the Threshold. Crit Care Nurs Q. 2016;39(4):387–8.
    1. Tamion F, Hamelin K, Duflo A, Girault C, Richard JC, Bonmarchand G. Gastric emptying in mechanically ventilated critically ill patients: effect of neuromuscular blocking agent. Intensive Care Med. 2003;29(10):1717–22.
    1. Grant K, Thomas R. Prokinetic drugs in the intensive care unit: reviewing the evidence. Journal of the Intensive Care Society. 2009;10:34e7.
    1. Ashouri E, Fatehi N. A comparison of performing tube feeding with the standard procedures at selected educational and treatment centers of Isfahan University of Medical Sciences, Iran. Iran J Nurs Midwifery Res. 2012;17(2 Suppl 1):S80–4.
    1. Napolitano LM, Bochicchio G. Enteral feeding of the critically ill. Curr Opin Crit Care. 2000;6(2):136–42.
    1. Doherty WL, Winter B. Prokinetic agents in critical care. Crit Care. 2003;7(3):206.
    1. Nguyen NQ, Ng MP, Chapman M, Fraser RJ, Holloway RH. The impact of admission diagnosis on gastric emptying in critically ill patients. Crit Care. 2007;11:1–R16.
    1. Landzinski J, Kiser TH, Fish DN, Wischmeyer PE, MacLaren R. Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition. JPEN J Parenter Enteral Nutr. 2008;32(1):45–50.
    1. Davies AR. Gastric residual volume in the ICU: can we do without measuring it? JPEN J Parenter Enteral Nutr. 2010;34(2):160–2.
    1. Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001;119(4):1222–41.
    1. Hsu CW, Sun SF, Lee DL, Lin SL, Wong KF, Huang HH, Li HJ. Impact of disease severity on gastric residual volume in critical patients. World J Gastroenterol. 2011;17(15):2007–12.
    1. Booth CM, Heyland DK, Paterson WG. Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence. Crit Care Med. 2002;30(7):1429–35.
    1. Lucey MA, Patil V, Girling K, Jacques T, O’Leary M. Does neostigmine increase gastric emptying in the critically ill?- results of a pilot study. Crit Care Resusc. 2003;5(1):14–9.
    1. Edwards SJ, Metheny NA. Measurement of gastric residual volume: state of the science. Medsurg Nurs. 2000;9(3):125–8.
    1. van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, Bosman RJ, Zandstra DF. Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure - a prospective, double-blind, placebo-controlled trial. Intensive Care Med. 2001;27(5):822–7.
    1. Emirleroglu M, Ekci B, Durgun V. The effect of neostigmine on postoperative ileus and the healing of colon anastomoses. Bratisl Lek Listy. 2011;112(6):309–13.
    1. Caliskan E, Turkoz A, Sener M, Bozdogan N, Gulcan O, Turkoz R. A prospective randomized double-blind study to determine the effect of thoracic epidural neostigmine on postoperative ileus after abdominal aortic surgery. Anesth Analg. 2008;106(3):959–64.
    1. Althausen PL, Gupta MC, Benson DR, Jones DA. The use of neostigmine to treat postoperative ileus in orthopedic spinal patients. J Spinal Disord. 2001;14(6):541–5.
    1. Aghadavoudi O, Abbasi S, Kashefi P, Golparvar M, Habibzade M, Kazemi S. Evaluation of intravenous neostigmine infusion on tolerance of enteral nutrition in Intensive Care Unit patients. J Res Med Sci. 2013;18(9):750–4.
    1. Imai K, Kitakoji H, Chihara E, Sakita M. Effects of atropine sulfate and neostigmine on gastric electrical activity in human subjects, electrogastrographic study. Hepatogastroenterology. 2008;55:294–7.
    1. Parthasarathy G, Ravi K, Camilleri M, Andrews C, Szarka LA, Low PA, et al. Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders. Neurogastroenterol Motil. 2015;27(12):1736–46.
    1. Nguyen NQ, Chapman MJ, Fraser RJ, Bryant LK, Holloway RH. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med. 2007;35:483–9.
    1. Avorn J, Gurwitz JH, Bohn RL, Mogun H, Monane M, Walker A. Increased incidence of levodopa therapy following metoclopramide use. JAMA. 1995;274(22):1780–2.
    1. Ganzini L, Casey DE, Hoffman WF, McCall AL. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993;153(12):1469–75.
    1. Vantrappen G. Methods to study gastric emptying. Dig Dis Sci. 1994;39:89s–94s.
    1. Beckers EJ, Leiper JB, Davidson J. Comparison of aspiration and scintigraphic techniques for the measurement of gastric emptying rates of liquids in humans. Gut. 1992;33(1):115–7.
    1. McClave SA, Snider HL, Lowen CC, McLaughlin AJ, Greene LM, McCombs RJ, et al. Use of residual volume as a marker for enteral feeding intolerance: prospective blinded comparison with physical examination and radiographic findings. JPEN J Parenter Enteral Nutr. 1992;16(2):99–105.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다